Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.

NCT07140640 is registered in ClinicalTrials.gov with Aswan University as lead sponsor.

NCT NCT07140640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07140640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.
Lead sponsor
Aswan University
Phase
Phase 4
Overall status
Recruiting
Start date
September 15, 2025
Completion date
September 30, 2026
Enrollment
666 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cesarean section complications